SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 83 filers reported holding SAVARA INC in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $221,710 | +5.1% | 44,520 | -0.9% | 0.00% | 0.0% |
| Q4 2023 | $211,044 | +23.8% | 44,903 | -0.4% | 0.00% | 0.0% |
| Q3 2023 | $170,418 | +45.3% | 45,084 | +22.9% | 0.00% | 0.0% |
| Q2 2023 | $117,247 | +102.2% | 36,697 | +30.8% | 0.00% | – |
| Q1 2021 | $58,000 | +81.2% | 28,064 | +0.3% | 0.00% | – |
| Q4 2020 | $32,000 | +3.2% | 27,989 | -2.8% | 0.00% | – |
| Q3 2020 | $31,000 | -56.3% | 28,792 | +1.4% | 0.00% | – |
| Q2 2020 | $71,000 | +61.4% | 28,390 | +38.2% | 0.00% | – |
| Q1 2020 | $44,000 | -54.6% | 20,538 | -5.5% | 0.00% | – |
| Q4 2019 | $97,000 | +67.2% | 21,725 | -0.8% | 0.00% | – |
| Q3 2019 | $58,000 | +20.8% | 21,907 | +8.5% | 0.00% | – |
| Q2 2019 | $48,000 | -64.4% | 20,199 | +10.5% | 0.00% | -100.0% |
| Q1 2019 | $135,000 | -5.6% | 18,274 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $143,000 | -32.5% | 18,866 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $212,000 | +15.2% | 19,011 | +16.8% | 0.00% | 0.0% |
| Q2 2018 | $184,000 | – | 16,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
| NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
| VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
| Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
| Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
| ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |